Delivery Order SPE2DE24D0013-SPE2D626F34M4
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $6,800 by the Defense Logistics Agency Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 8, 2025. The delivery order is for the KIT XPERT XPRESS COV-2 FLU RSV + MOL BIO, a molecular diagnostic testing kit designed to detect COVID-19, influenza, and respiratory syncytial virus. The contract carries no set-aside designation and will be performed in...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $5,440 firm fixed-price delivery order (4569923610) by the Defense Logistics Agency Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus—consistent with Cepheid's core competency in rapid molecular diagnostic testing...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a $68,000 firm fixed-price delivery order (Contract No. 4569923609, XPCOV2/FLU/RSV-10) by the Defense Logistics Agency Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 13, 2025. The delivery order, which carries no set-aside designation, is for diagnostic reagents and test kits related to COVID-19, influenza, and respiratory syncytial virus (RSV)...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $4,080 by the Defense Logistics Agency's Medical Supply Chain on November 24, 2025, with an ultimate completion date of December 2, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test cartridges for the detection of COVID-19, influenza, and respiratory syncytial virus. This award carries no set-aside designation and represents a...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $40,800 by the Defense Logistics Agency Medical Supply Chain on December 8, 2025, for diagnostic supplies supporting COVID-19, influenza, and respiratory syncytial virus (RSV) testing capabilities. The delivery order, designated XPCOV2/FLU/RSV-10, carries a firm fixed-price structure with an ultimate completion date of December 15, 2025, and is...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $40,946.80 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's GeneXpert diagnostic platform. The contract carries no...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $20,400 firm fixed-price delivery order (Contract No. 4569897059) by the Defense Logistics Agency Medical Supply Chain on October 31, 2025, with an ultimate completion date of November 7, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves the supply of molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV)—pathogens critical to military healthcare...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $6,120 by the Defense Logistics Agency Medical Supply Chain on December 16, 2025, with an ultimate completion date of December 23, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test kits for the company's GeneXpert diagnostic platform, specifically cartridges designed to detect COVID-19, influenza, and respiratory syncytial virus....
- Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, was awarded a delivery order valued at $2,040 on December 1, 2025, by the Defense Logistics Agency Medical Supply Chain. The delivery order, designated XPCOV2/FLU/RSV-10, carries a firm fixed-price structure with no set-aside designation and is scheduled for completion by December 8, 2025. Performance will take place at Cepheid's Sunnyvale facility. This delivery order represents procurement of diagnostic testing...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $12,240 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with ultimate completion by December 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus—infectious disease detection capabilities that align with the...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F34M4Delivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $6,800.00 by the Defense Logistics Agency Medical Supply Chain on December 17, 2025, with an ultimate completion date of December 23, 2025. The delivery order is for the KIT XPERT XPRESS COV-2 FLU RSV + MOL BIO—a rapid molecular diagnostic test kit designed to detect COVID-19, influenza, respiratory syncytial virus, and other respiratory pathogens. The contract utilized firm fixed-price pricing with no set-aside designation and is to be performed at Cepheid's location in Sunnyvale, California. This delivery order represents a routine procurement within Cepheid's established relationship as a primary federal supplier of diagnostic solutions across multiple federal healthcare agencies. Cepheid has demonstrated substantial capability in supplying molecular diagnostic equipment and reagents through extensive prior contracts, including two significant Indefinite Delivery Contracts with the Department of Veterans Affairs valued at approximately $6.7 million and $32.8 million, respectively, and ongoing work with the Defense Health Agency, Indian Health Service, and U.S. Coast Guard. The company's core competency in providing rapid molecular diagnostic testing solutions and GeneXpert platform-compatible test kits positions it as a critical supplier supporting federal healthcare operations and infectious disease surveillance capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 12/16/25 |